Perioperative β-blocker and statin therapy

Geraldine Daumerie, Lee A. Fleisher

Research output: Contribution to journalArticle

Abstract

PURPOSE OF REVIEW: Perioperative β-blockade and statin therapy have been advocated to reduce cardiac risk of noncardiac surgery. This review evaluates recent articles published on the cardioprotective effects of perioperative therapy with these medications. RECENT FINDINGS: Initial studies evaluating β-blocker therapy during the perioperative period suggested that β-blockers may be beneficial in reducing cardiac deaths and myocardial infarctions. Later studies and recent meta-analyses, however, are less favorable and suggest that β-blockers may be associated with increased incidence of bradycardia and hypotension. One randomized trial and several cohort studies have found a significant reduction in cardiovascular complications with perioperative statin therapy. Additionally, statin withdrawal is associated with increased postoperative cardiac risk. SUMMARY: Based upon the available evidence and guidelines, patients currently taking β-blockers should continue these agents. Patients undergoing vascular surgery who are at high cardiac risk should also take β-blockers. The question remains regarding the best protocol to initiate perioperative β-blockade. Statins should be continued in patients already taking these agents prior to surgery. The optimal duration and time of initiation of statin therapy remains unclear.

Original languageEnglish (US)
Pages (from-to)60-65
Number of pages6
JournalCurrent Opinion in Anaesthesiology
Volume21
Issue number1
DOIs
StatePublished - Feb 2008
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Therapeutics
Perioperative Period
Bradycardia
Hypotension
Blood Vessels
Meta-Analysis
Cohort Studies
Myocardial Infarction
Guidelines
Incidence

Keywords

  • Beta-adrenergic blockade
  • Guidelines
  • Myocardial ischemia
  • Statins

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Perioperative β-blocker and statin therapy. / Daumerie, Geraldine; Fleisher, Lee A.

In: Current Opinion in Anaesthesiology, Vol. 21, No. 1, 02.2008, p. 60-65.

Research output: Contribution to journalArticle

Daumerie, Geraldine ; Fleisher, Lee A. / Perioperative β-blocker and statin therapy. In: Current Opinion in Anaesthesiology. 2008 ; Vol. 21, No. 1. pp. 60-65.
@article{f23dd49524934e07b1b4fcb7af3a57ce,
title = "Perioperative β-blocker and statin therapy",
abstract = "PURPOSE OF REVIEW: Perioperative β-blockade and statin therapy have been advocated to reduce cardiac risk of noncardiac surgery. This review evaluates recent articles published on the cardioprotective effects of perioperative therapy with these medications. RECENT FINDINGS: Initial studies evaluating β-blocker therapy during the perioperative period suggested that β-blockers may be beneficial in reducing cardiac deaths and myocardial infarctions. Later studies and recent meta-analyses, however, are less favorable and suggest that β-blockers may be associated with increased incidence of bradycardia and hypotension. One randomized trial and several cohort studies have found a significant reduction in cardiovascular complications with perioperative statin therapy. Additionally, statin withdrawal is associated with increased postoperative cardiac risk. SUMMARY: Based upon the available evidence and guidelines, patients currently taking β-blockers should continue these agents. Patients undergoing vascular surgery who are at high cardiac risk should also take β-blockers. The question remains regarding the best protocol to initiate perioperative β-blockade. Statins should be continued in patients already taking these agents prior to surgery. The optimal duration and time of initiation of statin therapy remains unclear.",
keywords = "Beta-adrenergic blockade, Guidelines, Myocardial ischemia, Statins",
author = "Geraldine Daumerie and Fleisher, {Lee A.}",
year = "2008",
month = "2",
doi = "10.1097/ACO.0b013e3282f35ea5",
language = "English (US)",
volume = "21",
pages = "60--65",
journal = "Current Opinion in Anaesthesiology",
issn = "0952-7907",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Perioperative β-blocker and statin therapy

AU - Daumerie, Geraldine

AU - Fleisher, Lee A.

PY - 2008/2

Y1 - 2008/2

N2 - PURPOSE OF REVIEW: Perioperative β-blockade and statin therapy have been advocated to reduce cardiac risk of noncardiac surgery. This review evaluates recent articles published on the cardioprotective effects of perioperative therapy with these medications. RECENT FINDINGS: Initial studies evaluating β-blocker therapy during the perioperative period suggested that β-blockers may be beneficial in reducing cardiac deaths and myocardial infarctions. Later studies and recent meta-analyses, however, are less favorable and suggest that β-blockers may be associated with increased incidence of bradycardia and hypotension. One randomized trial and several cohort studies have found a significant reduction in cardiovascular complications with perioperative statin therapy. Additionally, statin withdrawal is associated with increased postoperative cardiac risk. SUMMARY: Based upon the available evidence and guidelines, patients currently taking β-blockers should continue these agents. Patients undergoing vascular surgery who are at high cardiac risk should also take β-blockers. The question remains regarding the best protocol to initiate perioperative β-blockade. Statins should be continued in patients already taking these agents prior to surgery. The optimal duration and time of initiation of statin therapy remains unclear.

AB - PURPOSE OF REVIEW: Perioperative β-blockade and statin therapy have been advocated to reduce cardiac risk of noncardiac surgery. This review evaluates recent articles published on the cardioprotective effects of perioperative therapy with these medications. RECENT FINDINGS: Initial studies evaluating β-blocker therapy during the perioperative period suggested that β-blockers may be beneficial in reducing cardiac deaths and myocardial infarctions. Later studies and recent meta-analyses, however, are less favorable and suggest that β-blockers may be associated with increased incidence of bradycardia and hypotension. One randomized trial and several cohort studies have found a significant reduction in cardiovascular complications with perioperative statin therapy. Additionally, statin withdrawal is associated with increased postoperative cardiac risk. SUMMARY: Based upon the available evidence and guidelines, patients currently taking β-blockers should continue these agents. Patients undergoing vascular surgery who are at high cardiac risk should also take β-blockers. The question remains regarding the best protocol to initiate perioperative β-blockade. Statins should be continued in patients already taking these agents prior to surgery. The optimal duration and time of initiation of statin therapy remains unclear.

KW - Beta-adrenergic blockade

KW - Guidelines

KW - Myocardial ischemia

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=38149098497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38149098497&partnerID=8YFLogxK

U2 - 10.1097/ACO.0b013e3282f35ea5

DO - 10.1097/ACO.0b013e3282f35ea5

M3 - Article

C2 - 18195612

AN - SCOPUS:38149098497

VL - 21

SP - 60

EP - 65

JO - Current Opinion in Anaesthesiology

JF - Current Opinion in Anaesthesiology

SN - 0952-7907

IS - 1

ER -